Extracellular vesicle profiling reveals novel autism signatures in patient-derived forebrain organoids.

Scientists grew mini-brain models in the lab using cells from autistic patients and healthy people. They studied tiny packages that brain cells release to communicate with each other. The packages from autistic brain models contained different proteins and genetic material compared to healthy ones. This could help us understand what causes autism and might lead to new ways to diagnose or treat it in the future.

This study investigated extracellular vesicles (EVs) - tiny cellular communication packages - secreted by brain tissue models derived from autism patients. Researchers used 3D lab-grown brain organoids from patient cells to analyze the contents of EVs compared to healthy controls. Using advanced molecular techniques including RNA sequencing and protein analysis, they found substantial differences in both RNA and protein content of autism-derived EVs. This represents the first characterization of altered EV profiles in autism models, potentially revealing new disease mechanisms.

The findings suggest EVs could serve as biomarkers for autism diagnosis or targets for therapeutic interventions, though this research is in early stages.

Findings suggest extracellular vesicles could serve as novel biomarkers for autism diagnosis or therapeutic targets. However, this is preliminary laboratory research using organoid models. Significant additional research is needed before any clinical applications, including validation in human studies and larger sample sizes.

Sample size not reported. Study uses organoid models which may not fully replicate human brain complexity. This is preliminary research requiring validation in larger studies and eventual human trials before clinical applications can be considered.

Autism Spectrum Disorder (ASD) affects 1 percent of the world's population with an increased prevalence of 178 percent since 2000. Although altered synaptic function putatively accounts for many of the abnormalities seen in ASD, the specific molecular mechanisms underlying this disorder remain poorly defined. A growing body of evidence suggests that extracellular vesicles (EVs), specifically exosomes, play a critical role in cellular communication within the brain. While they have been implicated in various types of diseases from cancer to neurodegeneration, their involvement in ASD remains largely unexplored.

In this study, we utilized patient-derived cortical organoid models to characterize EVs secreted by human three-dimensional (3D) tissue and defined their cargo. Our study reports, for the first time, alterations in ASD organoid-derived EVs in comparison to healthy control cortical EVs. By utilizing small RNA sequencing, proteomics, nanoparticle tracking and microscopy, we provide a comprehensive characterization of the cargo carried by EVs secreted from human 3D forebrain models. Our findings reveal substantial differences both in the RNA and protein content of ASD-derived EVs, providing insight into disease mechanisms as well as highlighting the potential of exosome-based diagnostics and therapies for ASD.